Jefferies Financial Group’s Harmony Biosciences HRMY Stock Holding History

Jefferies Financial Group’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.4M	Buy	+93,400	New	+$2.95M	0.02%	506
2026 Q1	–	Sell	-29,251	Closed	-$1.09M	–	1949
2025 Q4	$1.09M	Sell	29,251 -173,704	-86%	-$5.71M	0.01%	1030
2025 Q3	$5.59M	Buy	202,955 +32,385	+19%	+$1.12M	0.03%	342
2025 Q2	$5.39M	Buy	170,570 +26,326	+18%	+$847K	0.05%	280
2025 Q1	$4.79M	Sell	144,244 -161,356	-53%	-$5.78M	0.04%	303
2024 Q4	$10.5M	Buy	305,600 +89,000	+41%	+$3.06M	0.06%	217
2024 Q3	$8.66M	Buy	216,600 +166,100	+329%	+$5.83M	0.06%	201
2024 Q2	$1.52M	Buy	50,500 +25,000	+98%	+$752K	0.02%	617
2024 Q1	$856K	Buy	25,500 +4,800	+23%	+$154K	0.01%	872
2023 Q4	$669K	Buy	+20,700	New	+$578K	﹤0.01%	1106
2023 Q3	–	Sell	-10,000	Closed	-$352K	–	1767
2023 Q2	$352K	Buy	+10,000	New	+$345K	﹤0.01%	1279

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jefferies Financial Group's HRMY Position: Q2 2026 in Review

Jefferies Financial Group opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 93,400 shares worth $3.4M. The stake represents 0.02% of the portfolio and ranks #506 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in HRMY as recently as Q4 2025.

Jefferies Financial Group first reported a position in HRMY in Q2 2023 and has held it in 11 quarters since. The position peaked at $10.5M in Q4 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

Jefferies Financial Group held 93,400 shares of Harmony Biosciences worth $3.4M as of Q2 2026.
Harmony Biosciences was a new Jefferies Financial Group position in Q2 2026.
Harmony Biosciences made up 0.02% of Jefferies Financial Group's portfolio in Q2 2026, its #506 holding.
Jefferies Financial Group first reported a position in Harmony Biosciences in Q2 2023 and has held it in 11 quarters since.
Jefferies Financial Group's Harmony Biosciences position peaked at $10.5M in Q4 2024.
327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.